Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1989 Sep;27(9):2067–2072. doi: 10.1128/jcm.27.9.2067-2072.1989

Unsatisfactory specificities and sensitivities of six enzyme immunoassays for antibodies to hepatitis B core antigen.

G Caspari 1, H J Beyer 1, G Elbert 1, K Koerner 1, P Muss 1, F W Schunter 1, A Uy 1, W Gerlich 1, R Thomssen 1, H Schmitt 1
PMCID: PMC267740  PMID: 2674199

Abstract

To examine the consistency and comparability of anti-hepatitis B core antigen (anti-HBcAg) assays, four blood donation centers of the Red Cross in the Federal Republic of Germany tested 4,080 unselected blood donors with six different tests in parallel. Confirmation testing of reactive samples was done in the National Reference Center for Viral Hepatitis. Depending on the test kit used, 4.1 to 9.9% of serum samples were initially positive and 2.9 to 7.5% were repeatedly positive. Sixteen percent of serum samples were positive in at least one test but only three percent were positive in all six tests. Statistical analysis of frequency distribution of optical densities for each test suggested that there should be a correction of the cutoff values. This reduced the number of false-positive results by half, but a significant proportion of discrepant results could not be resolved. The lack of specificity and consistency requires cautious interpretation of isolated anti-HBcAg results in clinical specimens. Screening of predominantly anti-HBcAg-negative populations (e.g., blood donors) by the current anti-HBcAg test kits will almost necessarily give unsatisfactory results.

Full text

PDF
2067

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Koziol D. E., Holland P. V., Alling D. W., Melpolder J. C., Solomon R. E., Purcell R. H., Hudson L. M., Shoup F. J., Krakauer H., Alter H. J. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med. 1986 Apr;104(4):488–495. doi: 10.7326/0003-4819-104-4-488. [DOI] [PubMed] [Google Scholar]
  2. Kuo G., Choo Q. L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989 Apr 21;244(4902):362–364. doi: 10.1126/science.2496467. [DOI] [PubMed] [Google Scholar]
  3. Milich D. R., McLachlan A. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science. 1986 Dec 12;234(4782):1398–1401. doi: 10.1126/science.3491425. [DOI] [PubMed] [Google Scholar]
  4. Stevens C. E., Aach R. D., Hollinger F. B., Mosley J. W., Szmuness W., Kahn R., Werch J., Edwards V. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med. 1984 Dec;101(6):733–738. doi: 10.7326/0003-4819-101-6-733. [DOI] [PubMed] [Google Scholar]
  5. Troisi C. L., Hollinger F. B. Current tests for antibody to hepatitis b core antigen used to screen donors for non-A, non-B hepatitis are comparable to the original radioimmunoassay for hepatitis B core antigen. Transfusion. 1987 Sep-Oct;27(5):438–440. doi: 10.1046/j.1537-2995.1987.27587320541.x. [DOI] [PubMed] [Google Scholar]
  6. Zuck T. F., Sherwood W. C., Bove J. R. A review of recent events related to surrogate testing of blood to prevent non-A, non-B posttransfusion hepatitis. Transfusion. 1987 Mar-Apr;27(2):203–206. doi: 10.1046/j.1537-2995.1987.27287150202.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES